TC
ARCT icon

TownSquare Capital’s Arcturus Therapeutics ARCT Stock Holding History

TownSquare Capital’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-77,816
Closed -$3.38M – 567
2020
Q4 		$3.38M Buy
+77,816
New +$5.27M 0.15% 127
2019
Q4 		– Sell
-451,545
Closed -$4.54M – 469
2019
Q3 		$4.54M Buy
+451,545
New +$4.88M 0.38% 54

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TownSquare Capital's ARCT Position: Q1 2021 in Review

TownSquare Capital sold out of Arcturus Therapeutics (ARCT) in Q1 2021, closing a stake of 77,816 shares — an estimated $3.38M sold.

TownSquare Capital first reported a position in ARCT in Q3 2019 and held it in 2 quarters. The position peaked at $4.54M in Q3 2019. 162 funds tracked by Wall St. Rank hold ARCT as of Q1 2021.

  • TownSquare Capital reported no remaining Arcturus Therapeutics position as of Q1 2021 after selling out during the quarter.
  • TownSquare Capital sold 77,816 Arcturus Therapeutics shares in Q1 2021, an estimated $3.38M.
  • TownSquare Capital first reported a position in Arcturus Therapeutics in Q3 2019 and held it in 2 quarters.
  • TownSquare Capital's Arcturus Therapeutics position peaked at $4.54M in Q3 2019.
  • 162 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2021.

Based on TownSquare Capital's 13F filing for Q1 2021, filed 17 May 2021.